Inventor · disambiguated record
Elizabet Kaisheva
Also filed as: KAISHEVA ELIZABET · KAISHEVA ELIZABET A
4 granted patents·5 pending applications·96 citations·filing 2002–2014
78Inventor score
Files withKAISHEVA ELIZABET A2ABBOTT BIOTHERAPEUTICS CORP1EMERGENT BIOSOLUTIONS INC1FACET BIOTECH CORP1KAISHEVA ELIZABET1
Top patents by PatentIndex Score
9 records- 0193US7592004B2Stable lyophilized pharmaceutical formulation of IgG antibodiesFACET BIOTECH CORP·Filed 2005·Granted Sep 22, 2009·57 cites·10 claims
- 0290US8465739B2Stable aqueous pharmaceutical formulations of daclizumab antibodiesKAISHEVA ELIZABET A·Filed 2011·Granted Jun 18, 2013·30 cites·9 claims
- 0386US8298530B2Stable lyophilized pharmaceutical formulation of IgG antibodiesKAISHEVA ELIZABET A·Filed 2009·Granted Oct 30, 2012·8 cites·9 claims
- 0472US8778359B2Stable anthrax vaccine formulationsKAISHEVA ELIZABET·Filed 2009·Granted Jul 15, 2014·1 cites·19 claims
- 0558US2015023998A1Stable Anthrax Vaccine FormulationsEMERGENT BIOSOLUTIONS INC·Filed 2014·Application pending·0 cites
- 0654US2003138417A1Stable liquid pharmaceutical formulation of IgG antibodiesFiled 2002·Application pending·0 cites
- 0753US2003113316A1Stable lyophilized pharmaceutical formulation of IgG antibodiesFiled 2002·Application pending·0 cites
- 0848US2011070231A1Stable liquid pharmaceutical formulation of igg antibodiesABBOTT BIOTHERAPEUTICS CORP·Filed 2010·Application pending·0 cites
- 0946US2004009168A1Multidose antibody formulationFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →